Every one of those 1 sits in a single category, earnings. James Saccaro is most often covered alongside AI-enabled imaging solutions, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.5 for the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about James Saccaro
Every one of those 1 sits in a single category, earnings. James Saccaro is most often covered alongside AI-enabled imaging solutions, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 2.5 for the same window. Their average consequence score of 6 runs above the beat's 5.7 for that window. We currently track 1 Finance story that mention James Saccaro, all published on August 1, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 25 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering James Saccaro. Shared-story counts are live from our verified record — not editorial picks.
GE HealthCare beat Q2 expectations with $5.295 billion in revenue, up 5.7%, and reaffirmed full-year 2026 adjusted EPS of $4.80 to $5.00. The surprise CFO resignation introduces near-term uncertainty, but solid operational momentum and reaffirmed guidance may limit stock downside.